• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.通过对大量患者表达水平的分析确定 miRNA 和 mRNA 癌症特征。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19160-5. doi: 10.1073/pnas.1316991110. Epub 2013 Oct 7.
2
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.作为肺癌早期诊断潜在生物标志物的微小RNA差异表达谱
Oncol Rep. 2017 Jun;37(6):3543-3553. doi: 10.3892/or.2017.5612. Epub 2017 Apr 28.
3
Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.mRNA 和 miRNA 谱的综合分析揭示了 miR-193 和 miR-210 作为不同乳腺癌分子亚型潜在调控生物标志物的作用。
BMC Cancer. 2021 Jan 18;21(1):76. doi: 10.1186/s12885-020-07731-2.
4
Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.识别与乳腺癌亚型相关的重要微小RNA-信使核糖核酸对。
Mol Biol Rep. 2016 Jul;43(7):591-9. doi: 10.1007/s11033-016-4021-z. Epub 2016 May 31.
5
Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.竞争性内源性RNA网络分析确定了不同乳腺癌亚型中的关键基因。
Oncotarget. 2017 Feb 7;8(6):10171-10184. doi: 10.18632/oncotarget.14361.
6
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.对喉鳞状细胞癌中lncRNAs、mRNAs和miRNAs的差异表达谱进行综合分析,以构建ceRNA网络并鉴定潜在生物标志物。
J Cell Biochem. 2019 Oct;120(10):17963-17974. doi: 10.1002/jcb.29063. Epub 2019 May 24.
7
Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types.基于 miRNA-mRNA 下一代测序数据的综合分析,寻找不同癌症类型中的关联。
Comput Biol Chem. 2020 Feb;84:107152. doi: 10.1016/j.compbiolchem.2019.107152. Epub 2019 Nov 18.
8
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
9
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.与三阴性乳腺癌患者生存相关的整合 microRNA 和 mRNA 特征。
PLoS One. 2013;8(2):e55910. doi: 10.1371/journal.pone.0055910. Epub 2013 Feb 6.
10
Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.基于血清的六种miRNA特征作为子宫内膜癌诊断的潜在标志物:与TCGA miRNA测序数据集的比较以及通过整合分析TCGA miRNA测序和RNA测序数据集鉴定miRNA-mRNA靶标对
Asia Pac J Clin Oncol. 2018 Oct;14(5):e289-e301. doi: 10.1111/ajco.12847. Epub 2018 Jan 30.

引用本文的文献

1
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy.肿瘤中的免疫调节 microRNAs,其在诊断和治疗中的临床相关性。
J Immunother Cancer. 2024 Aug 29;12(8):e009774. doi: 10.1136/jitc-2024-009774.
2
MicroRNA-34 and gastrointestinal cancers: a player with big functions.微小RNA-34与胃肠道癌症:一个功能强大的参与者。
Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.
3
The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer.头颈部癌免疫原性放疗以及免疫治疗和靶向治疗中的新参与者。
Front Oral Health. 2023 Jul 11;4:1180869. doi: 10.3389/froh.2023.1180869. eCollection 2023.
4
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.通过综合生物信息学分析鉴定和验证胰腺导管腺癌的微小RNA和枢纽基因
J Gastrointest Oncol. 2023 Apr 29;14(2):719-732. doi: 10.21037/jgo-23-192.
5
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review.细胞穿透肽与纳米材料的结合用于治疗中枢神经系统疾病的潜在疗法:综述。
J Nanobiotechnology. 2021 Aug 23;19(1):255. doi: 10.1186/s12951-021-01002-3.
6
Anatomy of DNA methylation signatures: Emerging insights and applications.DNA 甲基化特征的剖析:新出现的见解与应用。
Am J Hum Genet. 2021 Aug 5;108(8):1359-1366. doi: 10.1016/j.ajhg.2021.06.015. Epub 2021 Jul 22.
7
MiR-664-3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix.miR-664-3p 通过靶向 Smad4 和 Osterix 抑制成骨细胞分化并损害骨形成。
J Cell Mol Med. 2021 Jun;25(11):5025-5037. doi: 10.1111/jcmm.16451. Epub 2021 May 4.
8
Altered Organelle Calcium Transport in Ovarian Physiology and Cancer.卵巢生理与癌症中细胞器钙转运的改变
Cancers (Basel). 2020 Aug 10;12(8):2232. doi: 10.3390/cancers12082232.
9
Thermodynamic energetics underlying genomic instability and whole-genome doubling in cancer.癌症中基因组不稳定性和全基因组加倍的热力学能量学基础。
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18880-18890. doi: 10.1073/pnas.1920870117. Epub 2020 Jul 21.
10
State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid Leukemia.基于时间序列的基因表达状态转换分析鉴定出预测急性髓系白血病发生的关键节点。
Cancer Res. 2020 Aug 1;80(15):3157-3169. doi: 10.1158/0008-5472.CAN-20-0354. Epub 2020 May 15.

本文引用的文献

1
Surprisal analysis of transcripts expression levels in the presence of noise: a reliable determination of the onset of a tumor phenotype.在噪声存在的情况下对转录本表达水平进行惊讶分析:可靠确定肿瘤表型的发生。
PLoS One. 2013 Apr 23;8(4):e61554. doi: 10.1371/journal.pone.0061554. Print 2013.
2
Free energy rhythms in Saccharomyces cerevisiae: a dynamic perspective with implications for ribosomal biogenesis.酿酒酵母中的自由能节律:对核糖体生物发生有影响的动态观点。
Biochemistry. 2013 Mar 5;52(9):1641-8. doi: 10.1021/bi3016982. Epub 2013 Feb 20.
3
mTOR in aging, metabolism, and cancer.mTOR 在衰老、代谢和癌症中的作用。
Curr Opin Genet Dev. 2013 Feb;23(1):53-62. doi: 10.1016/j.gde.2012.12.005. Epub 2013 Jan 11.
4
Circulating microRNAs as specific biomarkers for breast cancer detection.循环 microRNAs 作为乳腺癌检测的特异性生物标志物。
PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3.
5
Preferential regulation of stably expressed genes in the human genome suggests a widespread expression buffering role of microRNAs.人类基因组中稳定表达基因的优先调控表明 microRNAs 广泛发挥表达缓冲作用。
BMC Genomics. 2012;13 Suppl 7(Suppl 7):S14. doi: 10.1186/1471-2164-13-S7-S14. Epub 2012 Dec 13.
6
MicroRNAs in the cancer clinic.癌症临床中的微小RNA
Front Biosci (Elite Ed). 2013 Jan 1;5(1):204-13. doi: 10.2741/e608.
7
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy.靶向癌症的特征:迈向新一代癌症治疗的合理方法。
Curr Opin Oncol. 2013 Jan;25(1):50-1. doi: 10.1097/CCO.0b013e32835b651e.
8
TPT1/ TCTP-regulated pathways in phenotypic reprogramming.TPT1/TCTP 调控表型重编程途径。
Trends Cell Biol. 2013 Jan;23(1):37-46. doi: 10.1016/j.tcb.2012.10.002. Epub 2012 Oct 30.
9
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages.小鼠组织巨噬细胞的特征和多样性所依赖的基因表达谱和转录调控途径。
Nat Immunol. 2012 Nov;13(11):1118-28. doi: 10.1038/ni.2419. Epub 2012 Sep 30.
10
ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.ENTPD5介导的ATP调节导致多形性胶质母细胞瘤的代谢改变和存活率降低。
Tumour Biol. 2012 Dec;33(6):2411-21. doi: 10.1007/s13277-012-0505-1. Epub 2012 Sep 20.

通过对大量患者表达水平的分析确定 miRNA 和 mRNA 癌症特征。

miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.

机构信息

Institute for Molecular Medicine and Crump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.

出版信息

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19160-5. doi: 10.1073/pnas.1316991110. Epub 2013 Oct 7.

DOI:10.1073/pnas.1316991110
PMID:24101511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3839764/
Abstract

Toward identifying a cancer-specific gene signature we applied surprisal analysis to the RNAs expression behavior for a large cohort of breast, lung, ovarian, and prostate carcinoma patients. We characterize the cancer phenotypic state as a shared response of a set of mRNA or microRNAs (miRNAs) in cancer patients versus noncancer controls. The resulting signature is robust with respect to individual patient variability and distinguishes with high fidelity between cancer and noncancer patients. The mRNAs and miRNAs that are implicated in the signature are correlated and are known to contribute to the regulation of cancer-signaling pathways. The miRNA and mRNA networks are common to the noncancer and cancer patients, but the disease modulates the strength of the connectivities. Furthermore, we experimentally assessed the cancer-specific signatures as possible therapeutic targets. Specifically we restructured a single dominant connectivity in the cancer-specific gene network in vitro. We find a deflection from the cancer phenotype, significantly reducing cancer cell proliferation and altering cancer cellular physiology. Our approach is grounded in thermodynamics augmented by information theory. The thermodynamic reasoning is demonstrated to ensure that the derived signature is bias-free and shows that the most significant redistribution of free energy occurs in programming a system between the noncancer and cancer states. This paper introduces a platform that can elucidate miRNA and mRNA behavior on a systems level and provides a comprehensive systematic view of both the energetics of the expression levels of RNAs and of their changes during tumorigenicity.

摘要

为了确定癌症特异性基因特征,我们对一大组乳腺癌、肺癌、卵巢癌和前列腺癌患者的 RNA 表达行为应用了惊讶分析。我们将癌症表型状态描述为一组 mRNA 或 microRNAs (miRNAs) 在癌症患者与非癌症对照中的共同反应。该特征对于个体患者的变异性具有稳健性,并且能够高度准确地区分癌症患者和非癌症患者。涉及该特征的 mRNA 和 miRNAs 相关,并且已知它们有助于癌症信号通路的调控。miRNA 和 mRNA 网络在非癌症和癌症患者中是共同的,但疾病调节了连通性的强度。此外,我们还实验评估了癌症特异性特征作为可能的治疗靶点。具体来说,我们在体外重新构建了癌症特异性基因网络中单一占主导地位的连通性。我们发现了从癌症表型的偏离,显著降低了癌细胞的增殖并改变了癌症细胞的生理。我们的方法基于热力学,并通过信息论进行了增强。热力学推理被证明可以确保导出的特征是无偏差的,并表明在将系统编程为非癌症和癌症状态之间,自由能的最大重新分配发生。本文介绍了一个平台,可以在系统水平上阐明 miRNA 和 mRNA 的行为,并提供了关于 RNA 表达水平的能量学及其在肿瘤发生过程中的变化的全面系统观点。